Indication
Post-anesthesia respiratory depression
Post-anesthesia respiratory depression is a critical postoperative complication characterized by hypoventilation, decreased minute ventilation, or apnea following emergence from general anesthesia or procedural sedation. Read more about Post-anesthesia respiratory depression
4 drugs 4 manufacturers
Drugs that treat it
Common Post-anesthesia respiratory depression therapies.
DOXAPRAM HCL
DOPRAM (doxapram HCl)
DOPRAM (doxapram HCl)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPost-anesthesia respiratory depression is a critical postoperative complication characterized by hypoventilation, decreased minute ventilation, or apnea following emergence from general anesthesia or procedural sedation.
Primarily impacting the central nervous and respiratory systems, it results from the residual depressant effects of volatile anesthetics, intravenous sedatives, opioids, and neuromuscular blocking agents on brainstem respiratory centers and upper airway neuromuscular control.
Clinically, it presents during the early recovery period with reduced ventilatory drive, bradypnea, shallow breathing, hypercapnia, and hypoxemia, which can progress to respiratory arrest or severe hypoxic organ injury if uncorrected.
- nih.gov
Post-anesthesia respiratory depression is a critical postoperative complication characterized by hypoventilation, decreased minute ventilation, or apnea following emergence from general anesthesia or procedural sedation
- ahr-journal.org
Post-anesthesia respiratory depression is a critical postoperative complication characterized by hypoventilation, decreased minute ventilation, or apnea following emergence from general anesthesia or procedural sedation Clinically, it presents during the early recovery period with reduced ventilatory drive, bradypnea, shallow breathing, hypercapnia, and hypoxemia, which can progress to respiratory arrest or severe hypoxic organ injury if uncorrected
- scirp.org
Primarily impacting the central nervous and respiratory systems, it results from the residual depressant effects of volatile anesthetics, intravenous sedatives, opioids, and neuromuscular blocking agents on brainstem respiratory centers and upper airway neuromuscular control
- apsf.org
Primarily impacting the central nervous and respiratory systems, it results from the residual depressant effects of volatile anesthetics, intravenous sedatives, opioids, and neuromuscular blocking agents on brainstem respiratory centers and upper airway neuromuscular control Clinically, it presents during the early recovery period with reduced ventilatory drive, bradypnea, shallow breathing, hypercapnia, and hypoxemia, which can progress to respiratory arrest or severe hypoxic organ injury if un...
- bjbms.org
Primarily impacting the central nervous and respiratory systems, it results from the residual depressant effects of volatile anesthetics, intravenous sedatives, opioids, and neuromuscular blocking agents on brainstem respiratory centers and upper airway neuromuscular control
- nih.gov
Clinically, it presents during the early recovery period with reduced ventilatory drive, bradypnea, shallow breathing, hypercapnia, and hypoxemia, which can progress to respiratory arrest or severe hypoxic organ injury if uncorrected
Personalize your experience
Follow Post-anesthesia respiratory depression and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.